GNFC shareholders approve dividend, board changes at 50th AGM
- All six resolutions at GNFC's 50th AGM were approved by shareholders
- Promoters voted 100% in favor across all agenda items
- Dividend declaration for FY26 secured 99.99% support from polled votes
- Dr. T. Natarajan reappointed as director despite 16.79% opposition from institutions
- Total voting turnout reached 61.67% of outstanding shares

*this image is generated using AI for illustrative purposes only.
Gujarat Narmada Valley Fert & Chem shareholders approved all six resolutions at its 50th annual general meeting held on September 16, 2026. The meeting, conducted via video conferencing, saw strong participation from institutional investors.
The company’s promoters cast their entire stake of 60,693,667 shares in favor of every resolution, representing 100% voting support. Public institutions also showed high engagement, polling over 88% of their outstanding shares across most agenda items.
Key Resolutions Approved
Shareholders endorsed the audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026. The board’s recommendation to declare a dividend on equity shares for FY26 was passed with near-unanimous support, securing 99.99% affirmative votes on polled shares.
Board Appointments and Auditors
Dr. T. Natarajan, IAS (DIN: 00396367), who retires by rotation, was reappointed as a director. This resolution received 94.46% support overall, though it faced notable opposition from public institutions, which voted against it at a rate of 16.79%.
Prof. (Dr.) Mamata Biswal (DIN: 07156141) was appointed as an independent director via a special resolution, garnering 99.99% approval. The company also ratified the appointment of M/s. B S R and Co as statutory auditors and approved the remuneration for its cost auditor for the financial year 2026-27.
Voting Participation
Total votes polled stood at approximately 90.6 million out of 146.9 million outstanding shares, indicating a turnout of roughly 61.67%. Non-institutional public shareholders participated minimally, with e-voting turnout below 0.10% of their holdings, while poll voting during the meeting remained negligible.
What the Numbers Show
While promoter and institutional support was robust across operational resolutions, the reappointment of Dr. T. Natarajan revealed a divergence in sentiment. Although the resolution passed comfortably due to promoter backing, the 5.0 million shares voted against by public institutions suggest specific governance concerns or preferences within that investor segment, contrasting sharply with the unanimous support seen in the dividend and auditor resolutions.
Historical Stock Returns for Gujarat Narmada Valley Fert & Chem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +8.36% | +1.78% | +2.79% | +40.02% | +15.15% | +72.09% |
What specific governance concerns or strategic disagreements prompted the 16.79% opposition from public institutions against Dr. T. Natarajan's reappointment?
How might the appointment of Prof. Mamata Biswal as an independent director influence Gujarat Narmada Valley Fert & Chem's future strategic direction and board oversight?
Given the near-unanimous support for the FY26 dividend, does this signal a shift in capital allocation priorities towards shareholder returns over reinvestment in capacity expansion?


































